- $499.19m
- $470.91m
- $320.17m
AngioDynamics Inc reports results for the quarter ended in May - Earnings Summary
Brief: AngioDynamics Q4 Adjusted EPS USD -0.05
AngioDynamics Inc expected to post a loss of 16 cents a share - Earnings Preview
AngioDynamics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: AngioDynamics Announces CE Mark Approval In Europe For AlphaVac F18 System
Brief: AngioDynamics Presents APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System In Treatment Of Pulmonary Embolism
AngioDynamics Inc reports results for the quarter ended in February - Earnings Summary
Brief: AngioDynamics Q3 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.14
AngioDynamics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Angiodynamics Inc - On March 31, Co And Bd Entered Into A Settlement Agreement To Resolve Certain Litigation
Brief: Angiodynamics Announces Settlement Of All Patent Litigation With C.R. Bard, Inc.
Brief: Angiodynamics To Sell PICC And Midline Product Portfolios To Spectrum Vascular For $45 Mln
Brief: Angiodynamics Announces FDA 510(K) Clearance Of Auryon Xl Radial Access Catheter To Treat Peripheral Arterial Disease
Brief: Angiodynamics says Board Does Not Intend To Appoint New Director To Fill Vacancy Created By Dennis Meteny's Retirement, Reducing Board Size To 8 Directors
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. RESEARCH ROUNDUP- Agilon Health, Brown & Brown, Euronet Worldwide
U.S. STOCKS ON THE MOVE-CVS Health, Peloton, Eli Lilly
AngioDynamics Inc reports results for the quarter ended in November - Earnings Summary
U.S. STOCKS ON THE MOVE-Conagra Brands, Voyager Therapeutics, McDonald's